Lianbio Adr Stock Cash And Equivalents
| LIANDelisted Stock | USD 2.18 0.05 2.24% |
LianBio ADR fundamentals help investors to digest information that contributes to LianBio ADR's financial success or failures. It also enables traders to predict the movement of LianBio Stock. The fundamental analysis module provides a way to measure LianBio ADR's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LianBio ADR stock.
LianBio |
LianBio ADR Company Cash And Equivalents Analysis
LianBio ADR's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current LianBio ADR Cash And Equivalents | 329.3 M |
Most of LianBio ADR's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LianBio ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, LianBio ADR has 329.3 M in Cash And Equivalents. This is 59.88% lower than that of the Biotechnology sector and 26.35% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 87.81% higher than that of the company.
LianBio Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LianBio ADR's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LianBio ADR could also be used in its relative valuation, which is a method of valuing LianBio ADR by comparing valuation metrics of similar companies.LianBio ADR is currently under evaluation in cash and equivalents category among its peers.
LianBio Fundamentals
| Return On Equity | -0.32 | |||
| Return On Asset | -0.22 | |||
| Current Valuation | (182.65 M) | |||
| Shares Outstanding | 108.06 M | |||
| Shares Owned By Insiders | 5.90 % | |||
| Shares Owned By Institutions | 78.99 % | |||
| Number Of Shares Shorted | 378.13 K | |||
| Price To Book | 0.15 X | |||
| EBITDA | (105.26 M) | |||
| Net Income | (87.98 M) | |||
| Cash And Equivalents | 329.3 M | |||
| Cash Per Share | 3.04 X | |||
| Total Debt | 4.34 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 15.81 X | |||
| Book Value Per Share | 1.89 X | |||
| Cash Flow From Operations | (83.53 M) | |||
| Short Ratio | 0.40 X | |||
| Earnings Per Share | (0.82) X | |||
| Price To Earnings To Growth | (0.04) X | |||
| Target Price | 3.9 | |||
| Number Of Employees | 163 | |||
| Beta | 0.23 | |||
| Market Capitalization | 34.47 M | |||
| Total Asset | 319.96 M | |||
| Retained Earnings | (470.52 M) | |||
| Working Capital | 289.16 M | |||
| Annual Yield | 0.96 % | |||
| Net Asset | 319.96 M |
About LianBio ADR Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LianBio ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LianBio ADR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LianBio ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with LianBio ADR
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if LianBio ADR position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LianBio ADR will appreciate offsetting losses from the drop in the long position's value.Moving against LianBio Stock
| 0.71 | KEP | Korea Electric Power | PairCorr |
| 0.52 | VFSWW | VinFast Auto | PairCorr |
| 0.44 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
| 0.32 | EC | Ecopetrol SA ADR | PairCorr |
The ability to find closely correlated positions to LianBio ADR could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace LianBio ADR when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back LianBio ADR - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling LianBio ADR to buy it.
The correlation of LianBio ADR is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as LianBio ADR moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if LianBio ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for LianBio ADR can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in LianBio Stock
If you are still planning to invest in LianBio ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LianBio ADR's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |